Dr RR Baliga's "Got Knowledge Doc" Podkast

🔬 DO-HEALTH Trial Summary 🏋️‍♂️💊🧬

A randomized controlled trial (RCT) with 777 participants aged 70+ investigated the effects of omega-3 (🧴 1g/day), vitamin D (☀️ 2000 IU/day), and exercise (🏃‍♂️ 30 min, 3x/week) on biological aging using DNA methylation clocks.

📊 Key Findings:

✅ Omega-3 alone slowed biological aging by 2.9–3.8 months over 3 years.

✅ Combined interventions further reduced biological aging and improved health outcomes.

✅ Health benefits: 🔽 10% fall reduction, 🦠 13% lower infection rates, 💪 39% less prefrailty, 🛡️ 61% lower invasive cancer risk.

🔍 Conclusion: Omega-3, vitamin D, and exercise may slow biological aging and enhance healthspan. Further research is needed to assess long-term benefits. 🚀

🧠⚡🌊 Aging in Waves: How Your Brain, Body, and Organs Age at Different Speeds

1️⃣ Rapid Brain Aging Occurs at Three Distinct Ages 🧠⚡📆

• Scientists found that brain aging accelerates at ages 57, 70, and 78.

• These shifts impact memory, cognition, and neurodegeneration risks.

• Lifestyle choices like a healthy diet, exercise, and mental stimulation can help slow brain aging.

2️⃣ Feeling Suddenly Older? Scientists See Aging 'Waves' at 44 and 60 ⏳😲🌊

• Aging doesn't happen gradually but in distinct waves, especially at ages 44 and 60.

• Researchers found biomolecular shifts that may explain why people feel sudden declines.

• This suggests targeted interventions at key aging milestones could improve longevity.

3️⃣ Aging Isn't One-Size-Fits-All: How Your Organs Age at Different Speeds 🏥⏱️🔬

• Different organs age at different rates, meaning some parts of the body may wear out faster than others.

• Blood-based tests can now predict which organs are aging faster, helping detect early disease risks.

• This insight could personalize medicine, allowing for organ-specific interventions to slow aging.

🔍 Takeaway: Aging is not a smooth process—it happens in waves, varies by organ, and accelerates at key ages. Scientists are uncovering ways to track and slow these changes for better health and longevity. 🚀🧬

📌 Study Alert:

A longitudinal study across 23 countries (87,000 adults aged 50+) found that internet use 💻 is linked to better mental health 😊, fewer depressive symptoms 😌, and higher life satisfaction 🌟.

💡 Key Findings:

✅ Reduced depression in physically inactive & disabled individuals 🏥

✅ Improved well-being through social connections 🗣️

✅ Stronger benefits in China, England, & the U.S. 🇨🇳🇬🇧🇺🇸

⚠️ Challenges: Limited internet access & digital literacy in some regions 🌍❌

📢 Policy Implications: Expand internet access, promote digital literacy, and use online interventions for mental health 📶📚

Pythagoras of Samos (c. 570–495 BCE) was an ancient Greek philosopher and mathematician, best known for founding Pythagoreanism and the Pythagorean theorem.

His teachings combined mathematics, mysticism, and philosophy, influencing Plato, Western thought, and early science.

👁 JAMA Ophthalmology Study: Curcuma-based supplements (CBNS) may reduce AMD risk by 77% 📉, with 89% lower risk of advanced AMD and 54% lower risk of blindness 👀. More research is needed to confirm safety & efficacy 🔍.

🔬 Turmeric & Lead Contamination: 14% of South Asian turmeric samples contain lead chromate ⚠️, with hotspots in Patna, Karachi, and Peshawar 📍. Bangladesh successfully eliminated adulteration through strict regulations & awareness ✅.

⚖ Key Takeaways: Turmeric's dual nature 🌿—health benefits vs. lead risks ☠️—highlights the need for regulation, consumer awareness & safety measures ⚖️.

Nerinetide is a neuroprotective eicosapeptide designed to reduce ischemic brain injury by disrupting the interaction between N-methyl-D-aspartate (NMDA) receptors and downstream excitotoxic signaling.

It was tested in two major clinical trials for acute ischemic stroke:

• ESCAPE-NEXT Trial: Assessed Nerinetide in patients undergoing endovascular thrombectomy (EVT) without prior thrombolysis, finding no significant improvement in functional independence at 90 days.

• FRONTIER Trial: Evaluated prehospital Nerinetide administration within 3 hours of stroke onset, showing no overall benefit but potential efficacy in ischemic stroke patients receiving reperfusion therapy.

Although Nerinetide was safe, its clinical benefit remains uncertain, with timing and patient selection emerging as key factors for its potential role in stroke treatment. Further studies are needed to refine its use in combination with reperfusion therapies.

Acute hearing loss can be an early sign of posterior circulation stroke, particularly in anterior inferior cerebellar artery (AICA) infarctions.

However, hearing assessments are often overlooked due to the NIH Stroke Scale's focus on anterior strokes.

Real-world data showed missed diagnoses of vascular events when hearing loss was not evaluated. Integrating portable audiometry into stroke protocols could improve diagnostic accuracy and lead to timely interventions.

Three recent trials investigated the effectiveness of endovascular treatment (EVT) in ischemic stroke.

The OPENS-2 trial (Lancet 2025) found that normobaric hyperoxia combined with EVT improved 90-day functional outcomes for large-vessel occlusion stroke without increasing adverse events.

The DISTAL trial (NEJM 2025) reported no significant benefit of EVT over medical therapy for medium/distal vessel occlusions and noted a higher risk of hemorrhage.

Similarly, the ESCAPE-MeVO trial (NEJM 2025) found no improvement with EVT in medium-vessel occlusion stroke, alongside increased mortality and intracranial hemorrhage. Collectively, these findings suggest that EVT's benefits depend on vessel size and may be enhanced with adjunctive treatments like hyperoxia in specific cases.

🚨 VANISH2 Trial Alert! 🚑💙

Catheter ablation 🩺 proves superior to antiarrhythmic drugs 💊 for ventricular tachycardia in ischemic cardiomyopathy, reducing ICD shocks & VT storms! ⚡⬇️ #Cardiology #Electrophysiology #VT #ICD @NEJM

The Endocannabinoid System plays a crucial role in regulating cardiovascular, neurological, and immune functions through CB1 and CB2 receptors.

• CB1 Activation: Associated with oxidative stress, inflammation, and increased cardiovascular risks such as myocardial infarction (MI), arrhythmias, and heart failure.

• CB2 Activation: Primarily found in immune cells and linked to anti-inflammatory and protective cardiovascular effects.

• Cannabis Use: High THC content or synthetic cannabinoids (e.g., Spice, K2) significantly increases the risk of cardiovascular diseases and psychiatric disorders.

• Cannabis Use Disorder (CUD): Characterized by compulsive use despite adverse consequences, often co-occurring with depression, PTSD, and anxiety.

• Potential Therapeutic Targets: CB1 antagonists (e.g., Genistein) and CB2 agonists are being explored for their ability to reduce inflammation and vascular damage while minimizing psychiatric side effects.

Future research is needed to clarify long-term cardiovascular effects, optimize cannabinoid therapies, and inform public health policies.